Area of research
Internal Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Heparin-Induced Thrombocytopenia and Thrombosis, and COVID-19 Clinical Research Studies.
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned
Executive Summary: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE (PEACE) Consensus Conference*
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Recommendations on Monitoring and Replacement of Antithrombin, Fibrinogen, and Von Willebrand Factor in Pediatric Patients on Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Associations between <scp>ABO</scp> non‐identical platelet transfusions and patient <scp>outcomes—A</scp> multicenter retrospective analysis
Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network
Race, rituximab, and relapse in TTP
Antithrombotic Therapy for VTE Disease
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study
Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy
Thrombo‐inflammatory biomarkers and D‐dimer in a biracial cohort study
Antithrombotic therapy for left ventricular assist devices in adults: a systematic review
A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis